HomeEXECUTIVESAptar Digital Health Expands Oncology Clinical Advisory Board

Aptar Digital Health Expands Oncology Clinical Advisory Board

Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, today announced the expansion of its Oncology Clinical Advisory Board. Comprised of leading clinical, oncology and digital experts from across a wide range of cancer specialties, this newly formed Clinical Advisory Board will help provide critical review and scientific guidance to Aptar Digital Health on the development of its evidence-based medical algorithms.

The new members of the Aptar Digital Health Oncology Clinical Advisory Board include:

  1. Adam DICKER, MD, PhD – Chair and Professor of Radiation Oncology, Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, PA
  2. Marilyn HUANG, MD – Professor of Gynecologic Oncology, Director of Translational Gynecologic Oncology Research, University of Miami, Miami, FL
  3. Mario LACOUTURE, MD – Director of the Oncodermatology Program, Memorial Sloan Kettering Cancer Center, New York, NY
  4. Aditi U. JOSHI, MD, MSc – Emergency Medicine Physician, Telehealth and Digital Health Expert, US.

These members are welcomed by existing members of the Board, including:

Paolo BOSSI, MD, Prof. – Associate Professor, Medical Oncology, University of Brescia and ASST Spedali Civili, Brescia, Italy

Karin JORDAN, MD, Prof. – Head of Department of Hematology, Oncology and Palliative Care​, Ernst von Bergmann Clinic, Potsdam, Germany ​
Matti AAPRO, MD – Dean of Multidisciplinary Oncology Institute, Genolier Cancer Centre Switzerland

Guido CAVALETTI, MD – Head of the Neuroimmunology Center, S. Gerardo Hospital, Monza, Italy

Gregory LIP, MD – Cardio-Oncology Expertise, Liverpool Heart & Chest Hospital, Liverpool, UK.

Pere GASCON, MD, PhD – Chief of Medical Oncology and Scientific Coordinator, Hospital Clínic, Barcelona, Spain.

“We are pleased to strengthen our Clinical Advisory Board and to welcome our new members,” commented Pierre Leurent, President, Aptar Digital Health. “Their broad medical expertise will allow us to have a deeper knowledge and expand our global vision of the clinical practice for multiple types of cancer.”

Genevieve D’Orsay, MD, Chief Medical Officer at Aptar Digital Health added, “The Clinical Advisory Board contributes to the design of our clinical algorithms that support patients in the management of treatment-related symptoms. The contribution of each member is key to ensuring our solutions address a clinical need. Our Advisory Board also guides Aptar Digital Health in our clinical strategy decision, including the deployment of clinical studies.”

Medical Device News Magazinehttps://infomeddnews.com
Our publication is dedicated to bringing our readers the latest medical device news. We are proud to boast that our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall purpose and objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.


Dr John Parker will work closely with PeriGen's client base to optimize use of the company's analytics for patient care and research. He will also be instrumental in informing product development and regulatory affairs as PeriGen continues to expand its product suite and associated services.
“We’re delighted to welcome Gerald and Hannah to the PrecisionLife team at a time when our deep disease insights and patient stratification biomarkers are finding important new markets and bringing precision approaches to the early, more accurate diagnosis and care of patients with complex chronic diseases,” said Dr Steve Gardner, PrecisionLife CEO.
Broken String Biosciences reports Gavin Burns will be responsible for building and optimizing the companys teams, processes, and systems.
Dr Ronald Silverman will be responsible for leading the company's Medical Affairs organization, which includes end-to-end medical affairs across BD's business units, regions and central team. In this role, he will use medical insights and expertise to advance BD's pipeline of clinically relevant, innovative solutions that align with evolving patient needs, while also contributing to the safety and compliance of BD's in-market portfolio of products.
"Bill Hoffman is a widely respected and accomplished leader in the MedTech industry. The company is certain to benefit from his experience and insights as it looks to achieve its upcoming clinical milestones and future commercial goals," said Dr. David Israeli, CEO of Magenta Medical.

By using this website you agree to accept Medical Device News Magazine Privacy Policy